Correlation between maternal toxicity and embryo/fetal effects

Reproductive Toxicology

Volumn 13, Issue 5, 1999, Pages 375-381

  Chahoud, Ibrahim ^a   Ligensa, Anja ^a   Dietzel, Lutz ^b   Faqi, Ali S ^a  

^a Inst Clin Pharmacol and Toxicol   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Correlation; Embryo; Fetal toxicity; Maternal toxicity

Indexed keywords

TERATOGENIC AGENT;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONGENITAL MALFORMATION; CORRELATION FUNCTION; DRUG EFFECT; EMBRYO; EMBRYOTOXICITY; ENVIRONMENTAL EXPOSURE; FEMALE; FETOMATERNAL TRANSFUSION; FETOTOXICITY; FETUS; FETUS MALFORMATION; FETUS RESORPTION; FETUS WEIGHT; HUMAN; IATROGENIC DISEASE; LITTER SIZE; MALE; NONHUMAN; PREGNANCY; RAT; RAT STRAIN;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BODY WEIGHT; EMBRYO; FEMALE; FETAL RESORPTION; FETAL WEIGHT; FETUS; HUMANS; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; PREGNANCY; RATS; RATS, WISTAR; TERATOGENS;

EID: 0033197889     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(99)00035-0     Document Type: Article

References (17)

1. Palmer A.K. Regulatory requirements for reproductive toxicology theory and practice . Kimmel C., Buelke-Sam J. Developmental Toxicology, 1st ed. 1981;259-287 Raven Press, New York.
2. US EPA. Health effects test guidelines. Prenatal developmental toxicity (public draft). EPA 1996;712-C-96-207.
3. Butter H.S., Moffatt J.H., Foster B.C. Developmental toxicity of 4-substituted amphetamines in mice. Reprod Toxicol. 10:1996;301-310.
4. Faqi A.S., Schweinfurth H., Chahoud I. Determination of the no-effect dose of bis(tri-n-butyltin)oxide for maternal toxicity and teratogenicity in mice. Cong Anom. 37:1997;251-258.
5. Khera K.S. Maternal toxicity a possible etiological factor in embryo-fetal deaths and fetal malformations of rodent-rabbit species . Teratology. 1985;129-153.
6. Abel E.L., Sokol R.J. Maternal and fetal characteristics affecting alcohol's teratogenicity. Neuro Behav Toxicol Terat. 8:1986;329-334.
7. Molsted-Pedersen L. Pregnancy and diabetes a survey . Acta Endocrinol. 238:1980;13-19.
8. Fawcett L.B., Buck S.J., Brent R.L. Limb reduction defects in the A/J mouse strain associated with maternal blood loss. Teratology. 58:1998;183-189.
9. Graham J.M. Jr, Edwards M.J. Teratogen update gestational effects of maternal hyperthermia due to febrile illness and resultant patterns of defects in humans . Teratology. 58:1998;209-221.
10. Kavlock R.J., Chernoff N., Rogers E.H. The effect of acute maternal toxicity on fetal development in mouse. Teratogen Carcinogen Mutagen. (5):1985;3-13.
11. Ferrari D.A., Giles P.A., Klein N.W. Sera teratogenicity to cultured rat embryos in women with histories of spontaneous abortion. Teratology. 29:1984;31A.
12. Fu S.S., Sakanashi T.M., Rogers J.M., Hong K.H., Keen C.L. Influence of dietary folic acid on the developmental toxicity of methanol and the frequency of chromosomal breakage in the CD-1 mouse. Reprod Toxicol. 10:(6):1996;455-463.
13. Lewis D.P., Van Dyke D.C., Stumbo P.J., Berg M.J. Drug and environmental factors associated with adverse outcomes. Part 1: Antiepileptic drugs, contraceptives, smoking, and folate . Ann Pharmacother. 32:1998;802-817.
14. Duffy J.Y., Baines D., Overmann G.J., Keen C.L., Daston G.P. Repeated administration of α-hedrin results in alterations in maternal zinc status and adverse development outcome in the rat. Teratology. 56:1997;327-334.
15. Hurley L.S., Gowan J., Swenertaon H. Teratogenic effects of short-time and transitory zinc deficiency in rats. Teratology. 4:1971;199-204.
16. Murray F.J., John J.A., Balmer M.F., Schwetz B.A. Teratologic evaluation of styrene given to rats and rabbits by inhalation or by gavage. Toxicology. 11:1978;335-343.
17. Daston GP. Relationships between maternal and developmental toxicity. In: Kimmel C, Buelke-Sam J, editors. Developmental Toxicology, 2nd ed. New York: Raven Press, 1994. pp.189-212.